PEDIATRIC HEMATOLOGY AND ONCOLOGY 期刊简介
PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.
PHO: 小儿血液学和肿瘤学涵盖了血液疾病和儿童恶性疾病领域内的研究和患者管理的各个方面。我们的目标是使PHO: 小儿血液学和肿瘤学成为国际临床医生和科学家社区的首要期刊,他们共同致力于为患有癌症和血液疾病的儿童和年轻人定义最佳治疗策略。该杂志支持针对不同临床环境中的研究,特殊案例研究/系列的文章,这些文章增加了对发病机理和/或临床护理的新见解,并评论了联盟和会议中出现的发现和挑战。有关癌症发病机理,遗传学,分子诊断,药理学,干细胞,分子靶向,细胞和免疫疗法以及移植的临床研究以及基础和转化研究报告令人感兴趣。关注支持性护理,后期效果以及这些领域的相关伦理,法律,心理,社会,文化或历史方面的论文也受到赞赏。欢迎对该领域的重要发展进行审查。来自儿科血液学和肿瘤学国际社会的科学家和临床医生的文章被考虑出版。该期刊不依赖任何组织或社会,也不与任何组织或社会有联系。所有提交的材料在发布前都要经过严格的同行审查。我们的编辑委员会包括儿科血液学和肿瘤学专家,代表着广泛的学术和地理多样性。
期刊ISSN
|
0888-0018 |
影响指数
|
1.949 |
最新CiteScore值
|
1.90 查看CiteScore评价数据 |
最新自引率
|
3.10% |
官方指定润色网址
|
https://www.deeredit.com/?type=ss1 |
投稿语言要求
|
Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted. 建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率 |
期刊官方网址
hot |
https://www.peipusci.com/?type=9 |
杂志社征稿网址
hot |
https://www.peipusci.com/?type=10 |
通讯地址
|
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106 |
偏重的研究方向(学科)
|
医学-小儿科 |
出版周期
|
Bimonthly |
出版年份
|
1986 |
出版国家/地区
|
UNITED STATES |
是否OA
|
No |
SCI期刊coverage
|
Science Citation Index Expanded(科学引文索引扩展) |
NCBI查询
|
PubMed Central (PMC)链接 全文检索(pubmed central) |
最新中科院JCR分区
|
大类(学科)
小类(学科)
综述期刊
医学
HEMATOLOGY(血液学)4区
ONCOLOGY(肿瘤学)4区
PEDIATRICS(儿科)4区
否
|
|||||
最新的影响因子
|
1.949 | |||||
最新公布的期刊年发文量 |
|
|||||
总被引频次 | 38 | |||||
影响因子趋势图 |
近年的影响因子趋势图(整体平稳趋势)
|
2022年预警名单预测最新
最新CiteScore值
|
1.90
|
||||||||||||||||||
年文章数 | 98 | ||||||||||||||||||
SJR
|
0.499 | ||||||||||||||||||
SNIP
|
0.670 | ||||||||||||||||||
CiteScore排名
|
|
||||||||||||||||||
CiteScore趋势图 |
CiteScore趋势图
|
本刊同领域相关期刊
|
|
期刊名称 | IF值 |
Hematology-American Society of Hematology Education Program | 3.03 |
HEMOGLOBIN | 0.841 |
BIORHEOLOGY | 1.856 |
Blood Cancer Journal | 10.927 |
BLOOD | 21.892 |
LEUKEMIA | 11.413 |
Hematology | 2.246 |
HAEMOPHILIA | 4.244 |
TRANSFUSION | 3.125 |
本刊同分区等级的相关期刊
|
|
期刊名称 | IF值 |
HEMOGLOBIN | 0.841 |
BIORHEOLOGY | 1.856 |
Hematology | 2.246 |
VOX SANGUINIS | 2.123 |
Hamostaseologie | 1.76 |
LEUKEMIA RESEARCH | 3.124 |
ACTA HAEMATOLOGICA | 2.173 |
BLOOD PURIFICATION | 2.588 |
TRANSFUSION MEDICINE | 1.999 |
分享者 | 点评内容 |